Abstract
Epileptic seizures are frequent in elderly people; their seizures have sometimes different clinical manifestations. They also have risk for status epilepticus and it can be the first epilepsy manifestation. In this group of patients, drugs metabolism and side effects are different when compared with younger patients. It is also important when prescribing an antiepileptic drug, keeps in mind that most of the older people have another disease and are taking more than one medication. This principle applies when status epilepticus treatment is given to an elderly patient who also has another comorbility. New intravenous antiepileptic drugs like valproic acid, levetiracetam and laco- samide can be a choice in the status epilepticus treatment when the conventional medications are not indicated because of side effects; or when the patient has another medical condition. These new antiepileptic drugs are also useful in status epilepticus treatment, of patient with other medical conditions like liver failure or chemotherapy.
References
WATERHOUSE EJ. Continuum Lifelong Learning Neurol 2010;16:199-227.
WATERHOUSE EJ, TOWNE AR. Seizures in the Elderly. Nuances in presentation and treatment. Cleveland Clinic Journal of Medicine; 2005: 72 (Suppl 3); S26- S37.
POHLMANN-EDEN B. Issues when treating epilepsy in the elderly. Acta Neurol Scand 2005: 112 (Suppl 181): 40–46.
NIEDZIELSKA K, WIERZBICKA A, BARANSKA- GIERUSZCZAK M, LOJKOWSKA W, KURKOWSKA I, BOCHYNSKA A, PONIATOWSKA R, GLAZOWSKI C, JAKUBCZYK T WOLKOW. Status Epilepticus in Adults and Elderly: Aetiology, Clinical Manifestations and Prognosis. Epilepsia 2005; 46 (suppl 6):134.
BACHER J, ZARTL M, GLAWAR B, SPATT J, LEHNER E, KLAUSHOFER K, MAMOLI B. Status Epilepticus in Elderly. Epilepsia. 2003; 44 (suppl 8): 159-160
TOWNE AR, GARNETT LK, WATERHOUSE EJ, MORTON L, CAMPBELL ED, DELORENZO RJ. Status Epilepticus in the elderly population. Epilepsia. 2002; 43 (suppl 7): 243-244.
VAN DER LH, MARTYN ML, ANDRADE JQ, CASTRO LM, GROSSMAN RM. Nonconvulsive Status Epilepticus induced by Cefepime. Epilepsia 2004; 45 (Suppl 7):247-248.
ROMAN-FILIP C, ROCEANU A . The Caracteris- tics of Status Epilepticus in Elderly Patients Epilep- sia. 2003; 44 (suppl 8): 159
LITT B, WITYK RJ, HERTZ SH, MULLEN PD, WEISS H, RYAN DD, HENRY TR. No convulsive Status Epilepticus in the Critically ill elderly. Epilepsia, 1998; 39:1194-1202.
POZA-ALDEA JJ. Epilepsia en ancianos. Rev Neurol 2006; 42: 42-46
GOVANTES ESTESO C, VASQUEZ SOUSA MI, OCA BRAVOL. Manejo de Psicofármacos en situa- ciones especiales. En: Salazar Vallejo, M.; Peralta Rodrigo C, Pastor-Ruiz FJ. eds. Tratado de Psico- farmacología, Bases y aplicación clínica. Buenos Aires: Panamericana; 2010: 251-254.
CALLÉN-SOTOA, PÉREZ-PÉREZ S, ROBLES- DEL OLMOB. Estatus epiléptico no convulsivo revertido con levetiracetam endovenoso. Rev Neurol 2008; 47: 501-502.
AIGUABELLA MF, VILLANUEVA V, DE LA PEÑA P, MOLINS A, GARCIA-MORALES I, SAIZ R, PARDO J, TORTOSA D, SANSA G, MIRÓ J. Efficacy of intravenous Levetiracetam as an add-on tretament in status epilepticus: A multicentric observational Study. Seizures 2011; 20: 60-64
FATTOUCH J, DI BONAVENTURA C, CAS- CIATO S, BONINI F, PETRUCCI S, LAPENTA L, MANFREDI M, PRENCIPE M, GIALLONARDO AT. Intravenous Levtiracetam as first-line treatment of status epilepticus in the elderly. Acta Neurol Scand: 2010;121: 418–421
ADAMS RD, FOLEY JM. The neurological dis- order associated with liver disease. Proc Assoc for Res Nerv Ment Dis 1953;32:198-237.
KRASKO A, DESHPANDE K, BONVINOS. Liver failure, transplantation and critical care. Crit Care Clin 2003; 19:155-83).
ANDERSON GD. Pharmacogenetics and enzyme induction/inhibition properties of antiepileptic drugs. Neurology 2004;63: S3-S8.
PRIMAVERA A, AUDENIDO D. Cyclic Hyper- ammoniemic encephalopathy an epileptiform trypha- sic waves: problems in differential diagnosis with non convulsive status epilepticus. Neurol Sci 2009; 30: 175
SHET RD. Metabolic Concerns Associated with Antiepileptic Medications. Neurology 2004;63 (Suppl 4):S24-9
LEWIS MB, HOWDLE PD. Neurologic compli- cations of liver transplantation in adults. Neurology 2003;61:1174-1178.
SUN DA, SOMBATI, S, DELORENZO RJ. Guta- mate injury-induced epileptogenesis in hippocampal neuron: an in vitro model of stroke-induced epi- lepsy”. Stroke. 2001; 32:2344-2350.
UCHINO H, SMITH ML, BENGZON J, LUN- DGREN J, SIESJÖ BK. Characteristics of postisch- emic seizures in hyperglycemic rats. J Neurol Sci. 1996;139:21-27.
OSVALDO C, GOLDSTEIN L. Stoke. 2004; 35:1769-1775.
VELIOŠLU SK, ÖZMENOŠLU M, BOZ C, ALIOŠLU Z. Stroke. 2001;32:1169-1172.
MAZARATI AM, BALDWIN R, KLITGAARD H, MATAGNE A, WASTERLAIN CG. Anticonvulsant effects of levetiracetam and levetiracetam-diazepam combinations in experimental status epilepticus. Epi- lepsy Res. 2004;58:167-174
GIBBS JE, WALKER MC, COCK HR. Levetirace- tam: antiepileptic properties and protective effects on mitochondrial dysfunction in experimental status epilepticus. Epilepsia. 2006;47:469-478
KRAUS G, BEN-MANACHEN E, MAINENI- SKIENE R, VAICIENA-MAGISTRISN, BROCK M, WHITESIDES JG, JOHNSON ME. SP157 study group. Intravenous lacosamide as short-term replace- ment for oral lacosamiden parcial onset-seizures. Epi- lepsia 2010;57:951-957.
ROSENOW F, KNAKE S. Recent and future advences in treatment of status epilepticus. Therapeu- tic Advances in Ne urological Disorders. 2008; 1:33-42.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.